Angela Vitrano

846 total citations
23 papers, 288 citations indexed

About

Angela Vitrano is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Angela Vitrano has authored 23 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 17 papers in Hematology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Angela Vitrano's work include Hemoglobinopathies and Related Disorders (19 papers), Iron Metabolism and Disorders (14 papers) and Blood groups and transfusion (4 papers). Angela Vitrano is often cited by papers focused on Hemoglobinopathies and Related Disorders (19 papers), Iron Metabolism and Disorders (14 papers) and Blood groups and transfusion (4 papers). Angela Vitrano collaborates with scholars based in Italy, United States and Denmark. Angela Vitrano's co-authors include Aurelio Maggio, Aldo Filosa, Rosario Di Maggio, Giuseppina Calvaruso, Luciano Prossomariti, Lorella Pitrolo, Calogera Gerardi, Paolo Rigano, Liana Cuccia and Paolo Cianciulli and has published in prestigious journals such as Blood, British Journal of Haematology and American Journal of Hematology.

In The Last Decade

Angela Vitrano

20 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Vitrano Italy 9 229 210 63 37 32 23 288
Michele Rizzo Italy 7 270 1.2× 256 1.2× 63 1.0× 23 0.6× 48 1.5× 14 330
Rosario Di Maggio Italy 8 168 0.7× 156 0.7× 48 0.8× 15 0.4× 18 0.6× 25 214
Kallistheni Farmaki Greece 4 266 1.2× 251 1.2× 83 1.3× 19 0.5× 32 1.0× 7 295
Patrizia Cinque Italy 10 220 1.0× 189 0.9× 46 0.7× 22 0.6× 22 0.7× 21 255
Ioanna Tzoumari Greece 3 245 1.1× 229 1.1× 77 1.2× 18 0.5× 28 0.9× 6 270
GiovanBattista Leoni Italy 6 320 1.4× 295 1.4× 114 1.8× 19 0.5× 38 1.2× 6 351
Anne Nørd United States 3 307 1.3× 298 1.4× 54 0.9× 27 0.7× 39 1.2× 6 334
C. Murphy Ireland 6 137 0.6× 118 0.6× 17 0.3× 40 1.1× 6 0.2× 11 208
Roberto Malizia Italy 5 276 1.2× 254 1.2× 53 0.8× 6 0.2× 61 1.9× 5 306
Junwu Shen United Kingdom 5 96 0.4× 91 0.4× 34 0.5× 11 0.3× 11 0.3× 9 142

Countries citing papers authored by Angela Vitrano

Since Specialization
Citations

This map shows the geographic impact of Angela Vitrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Vitrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Vitrano more than expected).

Fields of papers citing papers by Angela Vitrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Vitrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Vitrano. The network helps show where Angela Vitrano may publish in the future.

Co-authorship network of co-authors of Angela Vitrano

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Vitrano. A scholar is included among the top collaborators of Angela Vitrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Vitrano. Angela Vitrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Musallam, Khaled M., Angela Vitrano, Rosario Di Maggio, et al.. (2025). Impact of lifetime anaemia and iron control on outcomes in β‐thalassaemia: Data from the longitudinal de‐LIGHT study. British Journal of Haematology. 207(4). 1578–1588.
2.
Vitrano, Angela, Rita Barone, Rosario Di Maggio, et al.. (2023). Overcoming the Cost Barrier for Thalassemia Innovative Treatments. Blood. 142(Supplement 1). 5200–5200. 3 indexed citations
3.
4.
Vitrano, Angela, Antonella Meloni, Mehran Karimi, et al.. (2020). A complication risk score to evaluate clinical severity of thalassaemia syndromes. British Journal of Haematology. 192(3). 626–633. 6 indexed citations
5.
Vitrano, Angela, Salvatore Scondotto, Gabriella Dardanoni, et al.. (2018). β-Thalassemia heterozygote state detrimentally affects health expectation. European Journal of Internal Medicine. 54. 76–80. 8 indexed citations
6.
Mancuso, Luigi, et al.. (2018). Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure. Hemoglobin. 42(1). 68–71. 14 indexed citations
7.
Vitrano, Angela, Giuseppina Calvaruso, Calogera Gerardi, et al.. (2016). The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?. British Journal of Haematology. 176(1). 124–130. 38 indexed citations
8.
Mancuso, Luigi, et al.. (2016). Diastolic Dysfunction with Normal Heart T2* in Thalassemia Major with Heart Failure. a Single Centre Study. Blood. 128(22). 2457–2457. 1 indexed citations
9.
Vitrano, Angela, et al.. (2016). Lower Levels of LPI in Thalassemia Major Patients Treated with Deferasirox. Blood. 128(22). 4821–4821. 1 indexed citations
10.
Giambona, Antonino, et al.. (2015). Earlier Antenatal Diagnosis of Hemoglobinopathies By Coelocentesis. Blood. 126(23). 2133–2133. 1 indexed citations
11.
12.
13.
Iacono, Melania Lo, et al.. (2015). Wharton's Jelly- MSC As Effective Tool for Expansion of Purified Human Cord Blood CD34+ Hematopoietic Stem Cells. Blood. 126(23). 4770–4770. 1 indexed citations
14.
Vitrano, Angela, Rosario Di Maggio, Samir K. Ballas, et al.. (2014). Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial. Blood Cells Molecules and Diseases. 53(4). 265–271. 16 indexed citations
15.
Vitrano, Angela, Giuseppina Calvaruso, Rosario Di Maggio, et al.. (2014). Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial. Blood. 124(21). 1354–1354. 2 indexed citations
16.
Filosa, Aldo, Angela Vitrano, Paolo Rigano, et al.. (2013). Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major. Blood Cells Molecules and Diseases. 51(2). 85–88. 26 indexed citations
17.
Maggio, Aurelio, Angela Vitrano, Marcello Capra, et al.. (2012). Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients. American Journal of Hematology. 87(7). 732–733. 30 indexed citations
18.
Maggio, Aurelio, Aldo Filosa, Angela Vitrano, et al.. (2011). Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials. Blood Cells Molecules and Diseases. 47(3). 166–175. 55 indexed citations
19.
Vitrano, Angela, et al.. (2011). Chelation treatment in sickle‐cell‐anaemia: much ado about nothing?. British Journal of Haematology. 154(5). 545–555. 28 indexed citations
20.
Vitrano, Angela, Liana Cuccia, Aurelio Maggio, et al.. (2010). Reliability of EMA Binding Test in the Diagnosis of Hereditary Spherocytosis in Italian Patients. Acta Haematologica. 125(3). 136–140. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele Rizzo Breakdown of academic impact, for papers by Rosario Di Maggio Breakdown of academic impact, for papers by Kallistheni Farmaki Breakdown of academic impact, for papers by Patrizia Cinque Breakdown of academic impact, for papers by Ioanna Tzoumari Breakdown of academic impact, for papers by GiovanBattista Leoni Breakdown of academic impact, for papers by Anne Nørd Breakdown of academic impact, for papers by C. Murphy Breakdown of academic impact, for papers by Roberto Malizia Breakdown of academic impact, for papers by Junwu Shen
Rankless by CCL
2026